A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Hydroxocobalamin Monohydrochloride | CAS 59461-30-2 - 请求报价

media.product.imagealternatetextformat.details

Hydroxocobalamin Monohydrochloride

SZ目录编号:SZ-H016009
CAS 号
59461-30-2
分子式
C62H89CoN13O15P : HCl
分子量
1346.4 : 36.5
投资状态
Synthesis on demand
Rel. CAS No13422-51-0 (free base) ; 58288-50-9 (XHCl salt)
运输条件 Room Temperature

化学名称 :

运输温度 :

HSN编码 :

原产国 :

微笑 :

使用说明:

Hydroxocobalamin Monohydrochloride is chemically Coα-[α-(5,6-dimethylbenzimidazolyl)]-Coβ-hydroxocobamide Hydrochloride (as per EP). Hydroxocobalamin Monohydrochloride is supplied with detailed characterization data compliant with regulatory guideline. Hydroxocobalamin Monohydrochloride can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Hydroxocobalamin Acetate.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

应用与法规使用场景

购买 59461-30-2

采购 59461-30-2

订购 59461-30-2

询问 59461-30-2

price of 59461-30-2

59461-30-2 供应商

59461-30-2 制造商

59461-30-2 出口商

buy high quality Hydroxocobalamin Monohydrochloride

采购 Hydroxocobalamin Monohydrochloride

Hydroxocobalamin Monohydrochloride 供应商

Hydroxocobalamin Monohydrochloride 制造商

Hydroxocobalamin Monohydrochloride 价格

订购 Hydroxocobalamin Monohydrochloride

询问 Hydroxocobalamin Monohydrochloride

Hydroxocobalamin Monohydrochloride 成本

Hydroxocobalamin Monohydrochloride 供应商

Hydroxocobalamin Monohydrochloride 分销商

Hydroxocobalamin Monohydrochloride 用于方法验证

Hydroxocobalamin Acetate 对照标准

Hydroxocobalamin Monohydrochloride 用于ANDA申报

Hydroxocobalamin Monohydrochloride 用于强制降解研究

Hydroxocobalamin Monohydrochloride 鉴别标准

Hydroxocobalamin Monohydrochloride 用于DMF申报

ℹ️

免责声明

SynZeal 在本网站上提供的产品信息是根据发布时的现有理解而提供的。客户在实际购买时有责任评估信息的准确性。

SynZeal 将根据产品规格的新发展或新发现更新这些详细信息,恕不另行通知。

,